{"version":"1.0","provider_name":"Laos Alliance Pharmaceutical Group","provider_url":"https:\/\/alliancepharmagroup.com\/lo","title":"ALITRAMETINIB - Laos Alliance Pharmaceutical Group","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"y1vbOMqz7K\"><a href=\"https:\/\/alliancepharmagroup.com\/lo\/\u0eaa\u0eb4\u0e99\u0e84\u0ec9\u0eb2\/alitrametinib\/\">ALITRAMETINIB<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/alliancepharmagroup.com\/lo\/\u0eaa\u0eb4\u0e99\u0e84\u0ec9\u0eb2\/alitrametinib\/embed\/#?secret=y1vbOMqz7K\" width=\"600\" height=\"338\" title=\"&#8220;ALITRAMETINIB&#8221; &#8212; Laos Alliance Pharmaceutical Group\" data-secret=\"y1vbOMqz7K\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/alliancepharmagroup.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/alliancepharmagroup.com\/wp-content\/uploads\/2024\/12\/Alitrametinib.png","thumbnail_width":1280,"thumbnail_height":1280,"description":"COMPOSITION Trametinib dimethyl sulfoxide....................................2mg INDICATION \u2022 Trametinib is a kinase inhibitor indicated as a single agent for the treatment of BRAF-inhibitor treatment-naive patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations. Or in combination with dabrafenib: \u2022 To treat unresectable or metastatic melanoma patients with BRAF V600E or V600K mutation positivity. \u2022 For postoperative adjuvant treatment of BRAF V600E or V600K mutation positive melanoma. \u2022 Used to treat metastatic non-small cell lung cancer caused by BRAF V600E mutation. PACKAGING: 30 tablets\/bottle. Reg No: 11 L 1256\/24 Download ALITRAMETINIB Drug Registration Certificate ... Read More"}